The Splanchnic and Systemic Circulation in Liver Disease

Chapter

Keywords

Liver blood flow Portal hypertension Portal flow Hepatic artery buffer response Splanchnic steal Vasoplegia 

References

  1. 1.
    Brown HS, et al. Measurement of normal portal venous blood flow by Doppler ultrasound. Gut. 1989;30:503–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Zardi EM, Di Matteo FM, Pacella CM, Sanyal AJ. Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review. Ann Med. 2014;46:8–17.CrossRefGoogle Scholar
  3. 3.
    Shah V, et al. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest. 1997;100:2923–30.CrossRefPubMedGoogle Scholar
  4. 4.
    Rincon D, et al. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment Pharmacol Ther. 2007;25:841–8.CrossRefGoogle Scholar
  5. 5.
    Wang YW, et al. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. J Clin Gastroenterol. 2007;41:706–12.CrossRefGoogle Scholar
  6. 6.
    Garcia-Tsao G, et al. Short-term effects of propranolol on portal venous pressure. Hepatology. 1986;6:101–6.CrossRefGoogle Scholar
  7. 7.
    Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest. 1953;32:1025–33.CrossRefPubMedGoogle Scholar
  8. 8.
    Lebrec D, Kotelanski B, Cohn JN. Splanchnic hemodynamics in cirrhotic patients with esophageal varices and gastrointestinal bleeding. Gastroenterology. 1976;70:1108–11.Google Scholar
  9. 9.
    Henriksen JH, Kiszka-Kanowitz M, Bendtsen F. Review article: volume expansion in patients with cirrhosis. Aliment Pharmacol Ther. 2002;16(Suppl 5):12–23.CrossRefGoogle Scholar
  10. 10.
    Frances R, et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology. 2004;39:484–91.CrossRefGoogle Scholar
  11. 11.
    Lin CY, et al. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol. 2007;46:816–26.CrossRefGoogle Scholar
  12. 12.
    Wasmuth HE, et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42:195–201.CrossRefGoogle Scholar
  13. 13.
    Wagener G, et al. Vasopressin deficiency and vasodilatory state in end-stage liver disease. J Cardiothorac Vasc Anesth. 2011;25:665–70.CrossRefPubMedGoogle Scholar
  14. 14.
    Wagener G, et al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl. 2008;14:1664–70.CrossRefGoogle Scholar
  15. 15.
    Dobre M, Demirjian S, Sehgal AR, Navaneethan SD. Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol. 2011;43:175–84.CrossRefGoogle Scholar
  16. 16.
    Guevara M, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology. 1998;27:35–41.CrossRefGoogle Scholar
  17. 17.
    Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg. 2012;29:6–17.CrossRefPubMedGoogle Scholar
  18. 18.
    Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2015;61:526–36.CrossRefPubMedGoogle Scholar
  19. 19.
    Zhong JH, Li LQ. Portal hypertension should not be a contraindication of hepatic resection to treat hepatocellular carcinoma with compensated cirrhosis. Hepatology. 2015;62:977–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Capussotti L, Ferrero A, Vigano L, Polastri R, Tabone M. Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. Eur J Surg Oncol. 2009;35:11–5.CrossRefGoogle Scholar
  21. 21.
    Olthoff KM, et al. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2015;21:79–88.CrossRefGoogle Scholar
  22. 22.
    Moon JI, et al. Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. Liver Transpl. 2010;16:864–9.CrossRefGoogle Scholar
  23. 23.
    Ben-Haim M, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient’s disease. Liver Transpl. 2001;7:948–53.CrossRefGoogle Scholar
  24. 24.
    Soejima Y, et al. Left lobe living donor liver transplantation in adults. Am J Transplant. 2012;12:1877–85.CrossRefGoogle Scholar
  25. 25.
    Soejima Y, et al. Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases. Am J Transplant. 2006;6:1004–11.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Columbia University Medical CenterNew YorkUSA
  2. 2.Department of AnesthesiologyColumbia University Medical CenterNew YorkUSA

Personalised recommendations